< 生产厂家价格 >

氯亚铂酸铵

氯亚铂酸铵用途

【用途一】
用作制备二氯二氨铂的原料。
【用途二】
制备氯钯酸铵的原料。

点击显示

氯亚铂酸铵名称

[ CAS 号 ]:
13820-41-2

[ 中文名 ]:
氯亚铂酸铵

[ 英文名 ]:
Platinum(II)-ammonium chloride

[中文别名 ]:

[英文别名 ]:

diammonium tetrachloroplatinate
Diammonium tetrachloroplatinate(2-)
Ammonium platinous chloride
Ammonium tetrachloroplatinate
EINECS 237-499-1
Diammonium tetrachloroplatinate (2-)
AMMONIUM CHLOROPLATINITE
Platinate(2-), tetrachloro-, ammonium (1:2)
AMMONIUMTETRACHLOROPLATINITE
Platinum(II)-ammonium chloride

氯亚铂酸铵物理化学性质

[ 密度 ]:
2.936 g/mL at 25 °C(lit.)

[ 熔点 ]:
140 °C (dec.)(lit.)

[ 分子式 ]:
H₈Cl₄N₂Pt

[ 分子量 ]:
372.96700

[ 精确质量 ]:
370.90900

[ LogP ]:
3.50790

[ 外观性状 ]:
金色-棕色晶体

[ 储存条件 ]:
库房通风低温干燥

[ 水溶解性 ]:
Soluble

氯亚铂酸铵MSDS

详细MSDS(安全技术说明书)

氯亚铂酸铵毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: TP1840000

CHEMICAL NAME :: Platinate(2-), tetrachloro-, diammonium

CAS REGISTRY NUMBER :: 13820-41-2

LAST UPDATED :: 199712

DATA ITEMS CITED :: 21

MOLECULAR FORMULA :: Cl4-Pt.2H4-N

MOLECULAR WEIGHT :: 372.99

WISWESSER LINE NOTATION :: .Z&2.PT-G4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 60 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 49,41,1979 *** REVIEWS *** ACGIH TLV-TWA 0.002 mg(Pt)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 0.002 mg(Pt)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,213,1971 OSHA PEL (Gen Indu):8H TWA 0.002 mg(Pt)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 0.002 mg(Pt)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 0.002 mg(Pt)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 0.002 mg(Pt)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 0.002 mg(Pt)/m3 (dust) JAN 1993 OEL-AUSTRALIA:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-BELGIUM:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-DENMARK:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-FINLAND:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-GERMANY:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-HUNGARY:STEL 0.002 mg(Pt)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-SWITZERLAND:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.002 mg(Pt)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV

点击显示

氯亚铂酸铵安全信息

[ 符号 ]:

GHS05, GHS06, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H301-H315-H317-H318-H334

[ 警示性声明 ]:
P261-P280-P301 + P310-P305 + P351 + P338-P342 + P311

[ 个人防护装备 ]:
Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T:Toxic;

[ 风险声明 (欧洲) ]:
R25;R28;R41;R42/43

[ 安全声明 (欧洲) ]:
S22-S26-S36/37/39-S45

[ 危险品运输编码 ]:
3288

[ WGK德国 ]:
1

[ RTECS号 ]:
TP1840000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1(b)

氯亚铂酸铵文献

Platinum complexes and pyruvate kinase activity.

Gen. Physiol. Biophys. 17(1) , 25-36, (1998)

The interaction of platinum complexes with bovine heart pyruvate kinase (PK) was studied by absorption, CD, fluorescence spectroscopy and enzymic activity test. Our results showed that activity of PK ...

Optimization of the efficiency of cross-linking PtII oligonucleotide phosphorothioate complexes to complementary oligonucleotides.

Nucleic Acids Res. 18(17) , 5163-71, (1990)

We have investigated the efficiency with which PtII complexes cross-link phosphorothioates of oligonucleotides to complementary DNA targets. The A and G residues 2-5 bases downstream from the 5'-phosp...

Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.

Int. J. Hyperthermia 11(4) , 575-86, (1995)

To investigate the greatest therapeutic efficacy, we investigated the effect of scheduling on the cytotoxic interaction between hyperthermia and seven different platinum complexes in vitro and in vivo...

更多文献